unknown
Stage
2
Investors
About
Zoundream AG develops AI-based technology that analyzes infant cries to assist parents and pediatricians in monitoring infant health and detecting potential neurodevelopmental disorders non-invasively at home.
Explore Zoundream AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.